Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carcinoma, Hepatocellular × Saline Solution × Clear all

Phase

Phase NA 2 Phase 2 2 Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 3 Neoplasms 2 Urinary Bladder Neoplasms 1 Spinal Cord Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion 1 Liver Neoplasms 1 Depression 1 Carcinoma, Hepatocellular 1

Interventions

Sorafenib 8 lenvatinib 5 apatinib 5 Oxaliplatin 5 Fluorouracil 5 sintilimab 4 Leucovorin 4 Folfox protocol 4 Bevacizumab 4 camrelizumab 3 atezolizumab 3 Capecitabine 3 tremelimumab 2 durvalumab 2 Radiosurgery 2 Nivolumab 2 Neoadjuvant Therapy 2 Injections 2 Hepatectomy 2 Gemcitabine 2 Ethiodized Oil 2 Drug Therapy 2 pirarubicin 1 menatetrenone 1 liposomal doxorubicin 1 lanreotide 1 halofantrine 1 donafenib 1 coenzyme Q10 1 budigalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01861912 2013-06-05

ACTION

Guangdong Provincial People's Hospital

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡